Loading…

Immunological abnormalities in myelodysplastic syndromes. Prospective study (series of 40 patients)

The association of myelodysplastic syndromes (MDS) with auto-immune diseases and humoral disorders have already been reported. In this prospective study we tried to estimate type and the frequency of immunological associated diseases among patients affected by MDS. In this prospective study, auto-im...

Full description

Saved in:
Bibliographic Details
Published in:La revue de medecine interne 2005-10, Vol.26 (10), p.777-783
Main Authors: Bouali, F, Berrah, A, Si Ahmed-Bouali, D, Harrieche, F, Benhalima, M, Hamladji, R M, Arrada, M
Format: Article
Language:fre
Subjects:
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by
cites
container_end_page 783
container_issue 10
container_start_page 777
container_title La revue de medecine interne
container_volume 26
creator Bouali, F
Berrah, A
Si Ahmed-Bouali, D
Harrieche, F
Benhalima, M
Hamladji, R M
Arrada, M
description The association of myelodysplastic syndromes (MDS) with auto-immune diseases and humoral disorders have already been reported. In this prospective study we tried to estimate type and the frequency of immunological associated diseases among patients affected by MDS. In this prospective study, auto-immune disease and humoral immunity disorders were systematically searched during MDS and conversely MDS searched during cytopenia. All MDS secondary to chemotherapy and the children's MDS were excluded. The MDS diagnosis was established according to FAB criteria and patients were classified in two groups A or B according to presence (group A) or not (group B) of dysimmune manifestations. Forty patients(19 males and 21 females, mean age of 56,6 years) with MDS have been enrolled during this period (group A: 20 patients). Associated diseases are following: systemic lupus erythematosus (three), lupus-like syndrome(one), sarcoidisis(one), Sjogrën syndrome(one), polyarthritis (two), chronic liver diseases (three), autoimmune thyroid diseases (two), pyoderma gangrenosum (one), Crohn's disease(one), haemolytic anaemia (one), and pericardial effusion(one). A wide spectrum of auto-immune manifestations is frequently reported in myelodysplastic syndromes. Further studies are necessary for discuss the current physiopathological hypothesis with their therapeutic relevance.
doi_str_mv 10.1016/j.revmed.2005.06.012
format article
fullrecord <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_proquest_miscellaneous_68697880</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>68697880</sourcerecordid><originalsourceid>FETCH-LOGICAL-p139t-791ae10c837a17f4b71eb75afc34d3f6bdc0632032c26a28c91dfe2b0ce692403</originalsourceid><addsrcrecordid>eNo1kD1PwzAURT2AaCn8A4Q8IRgSnu3USUZU8VGpEgwwR47zglzZcbCTSvn3pKJMdzn36OoScsMgZcDk4z4NeHDYpBxgnYJMgfEzsgSeFUkhpViQyxj3ADDT5QVZMMlBwHq9JHrr3Nh567-NVpaquvPBKWsGg5GajroJrW-m2FsVB6NpnLomeIcxpR_Bxx71YA5I4zA2E72PGI4939IMaK9mSTfEhyty3iob8fqUK_L18vy5eUt276_bzdMu6ZkohyQvmUIGuhC5Ynmb1TnDOl-rVousEa2sGw1SzMO55lLxQpesaZHXoFGWPAOxInd_3j74nxHjUDkTNVqrOvRjrGQhy7wojuDtCRzr-bWqD8apMFX_t4hfndFmSg</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>68697880</pqid></control><display><type>article</type><title>Immunological abnormalities in myelodysplastic syndromes. Prospective study (series of 40 patients)</title><source>ScienceDirect Freedom Collection 2022-2024</source><creator>Bouali, F ; Berrah, A ; Si Ahmed-Bouali, D ; Harrieche, F ; Benhalima, M ; Hamladji, R M ; Arrada, M</creator><creatorcontrib>Bouali, F ; Berrah, A ; Si Ahmed-Bouali, D ; Harrieche, F ; Benhalima, M ; Hamladji, R M ; Arrada, M</creatorcontrib><description>The association of myelodysplastic syndromes (MDS) with auto-immune diseases and humoral disorders have already been reported. In this prospective study we tried to estimate type and the frequency of immunological associated diseases among patients affected by MDS. In this prospective study, auto-immune disease and humoral immunity disorders were systematically searched during MDS and conversely MDS searched during cytopenia. All MDS secondary to chemotherapy and the children's MDS were excluded. The MDS diagnosis was established according to FAB criteria and patients were classified in two groups A or B according to presence (group A) or not (group B) of dysimmune manifestations. Forty patients(19 males and 21 females, mean age of 56,6 years) with MDS have been enrolled during this period (group A: 20 patients). Associated diseases are following: systemic lupus erythematosus (three), lupus-like syndrome(one), sarcoidisis(one), Sjogrën syndrome(one), polyarthritis (two), chronic liver diseases (three), autoimmune thyroid diseases (two), pyoderma gangrenosum (one), Crohn's disease(one), haemolytic anaemia (one), and pericardial effusion(one). A wide spectrum of auto-immune manifestations is frequently reported in myelodysplastic syndromes. Further studies are necessary for discuss the current physiopathological hypothesis with their therapeutic relevance.</description><identifier>ISSN: 0248-8663</identifier><identifier>DOI: 10.1016/j.revmed.2005.06.012</identifier><identifier>PMID: 16203055</identifier><language>fre</language><publisher>France</publisher><subject>Adult ; Aged ; Aged, 80 and over ; Anemia, Hemolytic - complications ; Arthritis - complications ; Autoimmune Diseases - complications ; Chronic Disease ; Crohn Disease - complications ; Female ; Humans ; Liver Diseases - complications ; Lupus Erythematosus, Systemic - complications ; Male ; Middle Aged ; Myelodysplastic Syndromes - complications ; Myelodysplastic Syndromes - immunology ; Myelodysplastic Syndromes - mortality ; Pericardial Effusion - complications ; Prospective Studies ; Pyoderma Gangrenosum - complications ; Sarcoidosis - complications ; Sjogren's Syndrome - complications ; Thyroid Diseases - complications</subject><ispartof>La revue de medecine interne, 2005-10, Vol.26 (10), p.777-783</ispartof><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27923,27924</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/16203055$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Bouali, F</creatorcontrib><creatorcontrib>Berrah, A</creatorcontrib><creatorcontrib>Si Ahmed-Bouali, D</creatorcontrib><creatorcontrib>Harrieche, F</creatorcontrib><creatorcontrib>Benhalima, M</creatorcontrib><creatorcontrib>Hamladji, R M</creatorcontrib><creatorcontrib>Arrada, M</creatorcontrib><title>Immunological abnormalities in myelodysplastic syndromes. Prospective study (series of 40 patients)</title><title>La revue de medecine interne</title><addtitle>Rev Med Interne</addtitle><description>The association of myelodysplastic syndromes (MDS) with auto-immune diseases and humoral disorders have already been reported. In this prospective study we tried to estimate type and the frequency of immunological associated diseases among patients affected by MDS. In this prospective study, auto-immune disease and humoral immunity disorders were systematically searched during MDS and conversely MDS searched during cytopenia. All MDS secondary to chemotherapy and the children's MDS were excluded. The MDS diagnosis was established according to FAB criteria and patients were classified in two groups A or B according to presence (group A) or not (group B) of dysimmune manifestations. Forty patients(19 males and 21 females, mean age of 56,6 years) with MDS have been enrolled during this period (group A: 20 patients). Associated diseases are following: systemic lupus erythematosus (three), lupus-like syndrome(one), sarcoidisis(one), Sjogrën syndrome(one), polyarthritis (two), chronic liver diseases (three), autoimmune thyroid diseases (two), pyoderma gangrenosum (one), Crohn's disease(one), haemolytic anaemia (one), and pericardial effusion(one). A wide spectrum of auto-immune manifestations is frequently reported in myelodysplastic syndromes. Further studies are necessary for discuss the current physiopathological hypothesis with their therapeutic relevance.</description><subject>Adult</subject><subject>Aged</subject><subject>Aged, 80 and over</subject><subject>Anemia, Hemolytic - complications</subject><subject>Arthritis - complications</subject><subject>Autoimmune Diseases - complications</subject><subject>Chronic Disease</subject><subject>Crohn Disease - complications</subject><subject>Female</subject><subject>Humans</subject><subject>Liver Diseases - complications</subject><subject>Lupus Erythematosus, Systemic - complications</subject><subject>Male</subject><subject>Middle Aged</subject><subject>Myelodysplastic Syndromes - complications</subject><subject>Myelodysplastic Syndromes - immunology</subject><subject>Myelodysplastic Syndromes - mortality</subject><subject>Pericardial Effusion - complications</subject><subject>Prospective Studies</subject><subject>Pyoderma Gangrenosum - complications</subject><subject>Sarcoidosis - complications</subject><subject>Sjogren's Syndrome - complications</subject><subject>Thyroid Diseases - complications</subject><issn>0248-8663</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2005</creationdate><recordtype>article</recordtype><recordid>eNo1kD1PwzAURT2AaCn8A4Q8IRgSnu3USUZU8VGpEgwwR47zglzZcbCTSvn3pKJMdzn36OoScsMgZcDk4z4NeHDYpBxgnYJMgfEzsgSeFUkhpViQyxj3ADDT5QVZMMlBwHq9JHrr3Nh567-NVpaquvPBKWsGg5GajroJrW-m2FsVB6NpnLomeIcxpR_Bxx71YA5I4zA2E72PGI4939IMaK9mSTfEhyty3iob8fqUK_L18vy5eUt276_bzdMu6ZkohyQvmUIGuhC5Ynmb1TnDOl-rVousEa2sGw1SzMO55lLxQpesaZHXoFGWPAOxInd_3j74nxHjUDkTNVqrOvRjrGQhy7wojuDtCRzr-bWqD8apMFX_t4hfndFmSg</recordid><startdate>200510</startdate><enddate>200510</enddate><creator>Bouali, F</creator><creator>Berrah, A</creator><creator>Si Ahmed-Bouali, D</creator><creator>Harrieche, F</creator><creator>Benhalima, M</creator><creator>Hamladji, R M</creator><creator>Arrada, M</creator><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>7X8</scope></search><sort><creationdate>200510</creationdate><title>Immunological abnormalities in myelodysplastic syndromes. Prospective study (series of 40 patients)</title><author>Bouali, F ; Berrah, A ; Si Ahmed-Bouali, D ; Harrieche, F ; Benhalima, M ; Hamladji, R M ; Arrada, M</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-p139t-791ae10c837a17f4b71eb75afc34d3f6bdc0632032c26a28c91dfe2b0ce692403</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>fre</language><creationdate>2005</creationdate><topic>Adult</topic><topic>Aged</topic><topic>Aged, 80 and over</topic><topic>Anemia, Hemolytic - complications</topic><topic>Arthritis - complications</topic><topic>Autoimmune Diseases - complications</topic><topic>Chronic Disease</topic><topic>Crohn Disease - complications</topic><topic>Female</topic><topic>Humans</topic><topic>Liver Diseases - complications</topic><topic>Lupus Erythematosus, Systemic - complications</topic><topic>Male</topic><topic>Middle Aged</topic><topic>Myelodysplastic Syndromes - complications</topic><topic>Myelodysplastic Syndromes - immunology</topic><topic>Myelodysplastic Syndromes - mortality</topic><topic>Pericardial Effusion - complications</topic><topic>Prospective Studies</topic><topic>Pyoderma Gangrenosum - complications</topic><topic>Sarcoidosis - complications</topic><topic>Sjogren's Syndrome - complications</topic><topic>Thyroid Diseases - complications</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Bouali, F</creatorcontrib><creatorcontrib>Berrah, A</creatorcontrib><creatorcontrib>Si Ahmed-Bouali, D</creatorcontrib><creatorcontrib>Harrieche, F</creatorcontrib><creatorcontrib>Benhalima, M</creatorcontrib><creatorcontrib>Hamladji, R M</creatorcontrib><creatorcontrib>Arrada, M</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>MEDLINE - Academic</collection><jtitle>La revue de medecine interne</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Bouali, F</au><au>Berrah, A</au><au>Si Ahmed-Bouali, D</au><au>Harrieche, F</au><au>Benhalima, M</au><au>Hamladji, R M</au><au>Arrada, M</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Immunological abnormalities in myelodysplastic syndromes. Prospective study (series of 40 patients)</atitle><jtitle>La revue de medecine interne</jtitle><addtitle>Rev Med Interne</addtitle><date>2005-10</date><risdate>2005</risdate><volume>26</volume><issue>10</issue><spage>777</spage><epage>783</epage><pages>777-783</pages><issn>0248-8663</issn><abstract>The association of myelodysplastic syndromes (MDS) with auto-immune diseases and humoral disorders have already been reported. In this prospective study we tried to estimate type and the frequency of immunological associated diseases among patients affected by MDS. In this prospective study, auto-immune disease and humoral immunity disorders were systematically searched during MDS and conversely MDS searched during cytopenia. All MDS secondary to chemotherapy and the children's MDS were excluded. The MDS diagnosis was established according to FAB criteria and patients were classified in two groups A or B according to presence (group A) or not (group B) of dysimmune manifestations. Forty patients(19 males and 21 females, mean age of 56,6 years) with MDS have been enrolled during this period (group A: 20 patients). Associated diseases are following: systemic lupus erythematosus (three), lupus-like syndrome(one), sarcoidisis(one), Sjogrën syndrome(one), polyarthritis (two), chronic liver diseases (three), autoimmune thyroid diseases (two), pyoderma gangrenosum (one), Crohn's disease(one), haemolytic anaemia (one), and pericardial effusion(one). A wide spectrum of auto-immune manifestations is frequently reported in myelodysplastic syndromes. Further studies are necessary for discuss the current physiopathological hypothesis with their therapeutic relevance.</abstract><cop>France</cop><pmid>16203055</pmid><doi>10.1016/j.revmed.2005.06.012</doi><tpages>7</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0248-8663
ispartof La revue de medecine interne, 2005-10, Vol.26 (10), p.777-783
issn 0248-8663
language fre
recordid cdi_proquest_miscellaneous_68697880
source ScienceDirect Freedom Collection 2022-2024
subjects Adult
Aged
Aged, 80 and over
Anemia, Hemolytic - complications
Arthritis - complications
Autoimmune Diseases - complications
Chronic Disease
Crohn Disease - complications
Female
Humans
Liver Diseases - complications
Lupus Erythematosus, Systemic - complications
Male
Middle Aged
Myelodysplastic Syndromes - complications
Myelodysplastic Syndromes - immunology
Myelodysplastic Syndromes - mortality
Pericardial Effusion - complications
Prospective Studies
Pyoderma Gangrenosum - complications
Sarcoidosis - complications
Sjogren's Syndrome - complications
Thyroid Diseases - complications
title Immunological abnormalities in myelodysplastic syndromes. Prospective study (series of 40 patients)
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-08T10%3A21%3A45IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Immunological%20abnormalities%20in%20myelodysplastic%20syndromes.%20Prospective%20study%20(series%20of%2040%20patients)&rft.jtitle=La%20revue%20de%20medecine%20interne&rft.au=Bouali,%20F&rft.date=2005-10&rft.volume=26&rft.issue=10&rft.spage=777&rft.epage=783&rft.pages=777-783&rft.issn=0248-8663&rft_id=info:doi/10.1016/j.revmed.2005.06.012&rft_dat=%3Cproquest_pubme%3E68697880%3C/proquest_pubme%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-p139t-791ae10c837a17f4b71eb75afc34d3f6bdc0632032c26a28c91dfe2b0ce692403%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=68697880&rft_id=info:pmid/16203055&rfr_iscdi=true